Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma.
暂无分享,去创建一个
J. Teruya-Feldstein | R. Chaganti | C. Hedvat | S. Nimer | J. Qin | Julie Teruya-Feldstein | Stephen D Nimer | Jing Qin | D. Filippa | Beiyun Chen | A. Hegde | Cyrus V Hedvat | Abhijith Hegde | Raju S k Chaganti | Daniel A Filippa | Beiyun Chen
[1] C. Cordon-Cardo,et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. , 2001, The American journal of pathology.
[2] D. Arber,et al. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[3] T. Yoshino,et al. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray. , 2001, The American journal of pathology.
[4] S. Hamilton-Dutoit,et al. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease , 1991, The Lancet.
[5] S. Perkins,et al. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas. , 2001, American journal of clinical pathology.
[6] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[7] D. Hossfeld. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .
[8] D. Arber,et al. CD10: A Review , 1997 .
[9] Bernard R. Rosner,et al. Fundamentals of Biostatistics. , 1992 .
[10] R. Warnke,et al. Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. , 1987, Human pathology.
[11] D. Rimm,et al. Validation of Tissue Microarray Technology in Breast Carcinoma , 2000, Laboratory Investigation.
[12] Yasodha Natkunam,et al. Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry , 2001, Modern Pathology.
[13] C. Cordon-Cardo,et al. p63 expression profiles in human normal and tumor tissues. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] R S Chaganti,et al. BCL8, a novel gene involved in translocations affecting band 15q11-13 in diffuse large-cell lymphoma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Ladanyi,et al. MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. , 1991, Blood.
[16] E. Jaffe,et al. Macrophage-Derived Chemokine Expression in Classical Hodgkin's Lymphoma: Application of Tissue Microarrays , 2001, Modern Pathology.
[17] K. Chang,et al. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. , 1999, American journal of clinical pathology.
[18] P. Koduru,et al. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. , 1997, Blood.
[19] J. Lasota,et al. Bcl‐2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B‐cell proliferations is of diagnostic value , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.